Some interesting developments on #PrEP availability in Japan:
1. In 2024 (12 years after the US), Truvada was approved for preventative use in Japan. Descovy still is not.
2. Prior to approval, clinics prescribing PrEP would import Truvada generics such as Tenvir-EM from abroad, with a cost to individuals of less than 10,000 JPY/mo.
3. After Descovy was approved for preventative use in the US, clinics started doing the same with Descovy generics such as Tafero-EM.
4. Now that Truvada has been approved for preventative use in Japan, however, clinics aren't able to import and prescribe generic Truvada from abroad.
5. Name-brand Truvada costs about 2442.2 JPY *per day* (73,272 JPY per month), and isn't covered by insurance.
So, most people using generic Truvada prescribed by a clinic for PrEP have basically two options: (1) Personal importation (legal subject to some restrictions) or (2) Switching to generic Descovy. Which, since it hasn't been approved for preventative use in Japan, clinics can still import and prescribe.
More comprehensive information in Japanese here: https://ph-clinic.org/blog/4219/